Supplementary Figures – Adjuvant EGFR tyrosine kinase inhibitors forpatients with resectedEGFR-mutatednon-small-cell lung cancer: a networkmeta-analysis

Supplementary Figures – Adjuvant EGFR tyrosine kinase inhibitors forpatients with resectedEGFR-mutatednon-small-cell lung cancer: a networkmeta-analysis

Figure 1: Risk classification Figure 2: Brooks–Gelmandiagnoses of astringency  Figure 3: Heterogeneity results of head-to-head comparisons in forest plots according to feasible pairwise, back-calculatedand network  Figure 4: Sensitivity analysis

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Future Science Group, Figshare, Tian, Wentao, Tan, Nuopei, Ke, Jiawen, Zou, Ji’an, Liu, Xiaohan, Pan, Yue, Zeng, Yue, Peng, Yurong, Wu, Fang
Format: Bild
Sprache:eng
Schlagworte:
Cancer therapy (excl. chemotherapy and radiation therapy)
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Figure 1: Risk classification Figure 2: Brooks–Gelmandiagnoses of astringency  Figure 3: Heterogeneity results of head-to-head comparisons in forest plots according to feasible pairwise, back-calculatedand network  Figure 4: Sensitivity analysis
DOI:10.25402/fon.20060171